Name: Latest research reports of Aarti Drugs Ltd. authored by Axis Direct and published by - Trendlyne research reports.
Item: Aarti Drugs Ltd.
Rating: 5
Author: Axis Direct

Aarti Drugs Ltd.

NSE: AARTIDRUGS | BSE: 524348 | ISIN: INE767A01016 | Industry: Pharmaceuticals
| Mid-range Performer

489.4000 -2.35 (-0.48%)

NSE Aug 11, 2025 15:31 PM

56.86% Gain from 52W Low

Volume: 96,219

Aarti Drugs Ltd.

20 May 2024

489.40

-0.48%

Pick of the Week:21 MAY 2024

Buy: Aarti Drugs Ltd.

Target

Axis Direct

We recommend a BUY rating on the stock with a target price of Rs 536/share, implying an upside of 10% from CMP

Aarti Drugs Ltd. is trading below its 30 day SMA of 504.1